- ICH GCP
- US Clinical Trials Registry
- Researchers
- Korea, Republic of
- Pancreatic Neoplasms
Medical specialists from Korea, Republic of tagged as investigators in clinical trials studying Pancreatic Neoplasms
Total 29 results
-
Dong Ho Lee, MDSeen in:
- Seoul, Seoul National University Hospital
Trials:- NCT05262452 (Sub-Investigator)
-
Dong Hyuk Park, TechnicianSeen in:
- Seoul, Seoul National University Hospital
Trials:- NCT05262452 (Sub-Investigator)
-
Eunsung Jun, MD., PhD.Seen in:
- Seoul, Asan Medical Center
Trials:- NCT03665571 (Sub-Investigator)
Conditions: -
Hang-Rae Kim, phDSeen in:
- Seoul, Seoul National University Hospital
Trials:- NCT05262452 (Sub-Investigator)
-
Ho-Seong Han, M.D.,Ph.D.Seen in:
- Kyeonggi-do, Seongnam-si, Seoul National University Bundang Hospital
Trials:- NCT03957135 (Principal Investigator)
Conditions: -
Hong Beom Kim, MDSeen in:
- Seoul, Seoul National University Hospital
Trials:- NCT05262452 (Sub-Investigator)
-
Hun Sik Kim, PhDSeen in:
- Seoul, Asan Medical Center
Trials:- NCT03665571 (Sub-Investigator)
Conditions: -
Hyewon RyuSeen in:
- Daejeon, Chungnam National University Hospital
Trials:- NCT06436976 (Principal Investigator)
Conditions: -
Hyun Ji Lee, CRCSeen in:
- Seoul, Seoul National University Hospital
Trials:- NCT05262452 (Sub-Investigator)
-
In Rae Cho, MDSeen in:
- Seoul, Seoul National University Hospital
Trials:- NCT05262452 (Sub-Investigator)
-
Jae Young Lee, MDSeen in:
- Seoul, Seoul National University Hospital
Trials:- NCT05262452 (Principal Investigator)
-
Jaihwan Kim, MDSeen in:
- Gyeonggi-do, Seongnam, Seoul National University Bundang Hospital
Trials:- NCT02862015 (Sub-Investigator)
Conditions: -
Jin Ho Choi, MDSeen in:
- Seoul, Sang Hyub Lee
- Seoul, Seoul National University Hospital
Trials:- NCT05497271 (Sub-Investigator)
- NCT05604573 (Sub-Investigator)
- NCT05596370 (Sub-Investigator)
-
Jin-Hyeok Hwang, MD PhDSeen in:
- Gyeonggi-do, Seongnam, Seoul National University Bundang Hospital
Trials:- NCT02862015 (Principal Investigator)
Conditions: -
Jin-Young Jang, MDSeen in:
- Seoul, Seoul National University Hospital
Trials:- NCT05262452 (Sub-Investigator)
-
Kim Dong-Wan, MDSeen in:
- Seoul, Seoul National University College of Medicine
Trials:- NCT02912949 (Principal Investigator)
-
Min Jae Yang, MD, PhDSeen in:
- Gyeong Gi Do, Suwon, Ajou University Hospital
Trials:- NCT05571956 (Principal Investigator)
Conditions: -
Myung-Ah Lee, M.D., Ph.D.Seen in:
- Seoul, Department of Internal Medicine, Seoul St. Mary's Hospital, Catholic University College of Medicine
Trials:- NCT05529940 (Principal Investigator)
-
Sang Hyub Lee, MD PhDSeen in:
- Seoul, Seoul National University Hospital
Trials:- NCT05497271 (Principal Investigator)
- NCT04416763 (Principal Investigator)
- NCT05604573 (Principal Investigator)
- NCT05596370 (Principal Investigator)
-
Sang Myung WooSeen in:
- Gyeonggi-do, Goyang-si, National Cancer Center-Korea
Trials:- NCT04239573 (Principal Investigator)
Conditions: -
Sang-Hyup Lee, MDSeen in:
- Seoul, Seoul National University Hospital
Trials:- NCT05262452 (Sub-Investigator)
-
Se Jun Park, M.D.Seen in:
- Seoul, Department of Internal Medicine, Seoul St. Mary's Hospital, Catholic University College of Medicine
Trials:- NCT05529940 (Sub-Investigator)
-
Seong Ho Choi, CRCSeen in:
- Seoul, Seoul National University Hospital
Trials:- NCT05262452 (Sub-Investigator)
-
Seungmin BangSeen in:
- Seoul, Yonsei University Health System-Severance Hospital
Trials:- NCT04239573 (Principal Investigator)
Conditions: -
Song Cheol KimSeen in:
- Seoul, Asan Medical Center
Trials:- NCT06388967 (Sub-Investigator)
Conditions:- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Pancreatic Adenocarcinoma;
- Pancreatic Ductal Adenocarcinoma;
- Pancreatic Cancer Resectable;
- Pancreatic Carcinoma;
- Pancreatic Cancer Non-resectable;
- Pancreatic Cancer Stage III;
- Pancreatic Cancer Stage;
- Pancreatic Cancer Stage II;
- Pancreatic Cancer, Adult;
- Pancreatic Cancer Stage I;
- Pancreatic Cancer Stage 0
-
Song-Cheol Kin Kim, MD, PhD.Seen in:
- Seoul, Asan Medical Center
Trials:- NCT03665571 (Principal Investigator)
Conditions: -
Soo Yeon Kang, CRCSeen in:
- Seoul, Seoul National University Hospital
Trials:- NCT05262452 (Sub-Investigator)
-
Yejong Park, MD, PhDSeen in:
- Seoul, Asan Medical Center
Trials:- NCT04357483 (Sub-Investigator)
Conditions: -
Yoo-Seok Yoon, M.D.,Ph.D.Seen in:
- Kyeonggi-do, Seongnam-si, Seoul National University Bundang Hospital
Trials:- NCT03957135 (Sub-Investigator)
Conditions:
Clinical Trials on Pancreatic Neoplasms
-
City of Hope Medical CenterRecruitingPancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Resectable | Pancreatic Carcinoma | Pancreatic Cancer Non-resectable | Pancreatic Cancer Stage III | Pancreatic Cancer Stage | Pancreatic Cancer Stage II | Pancreatic Cancer, Adult | Pancreatic... and other conditionsKorea, Republic of, United States, Japan
-
Memorial Sloan Kettering Cancer CenterRecruitingPancreatic Cancer | Pancreatic Cancer Metastatic | Pancreatic Cancer Stage IV | Metastatic Pancreatic Carcinoma | Metastatic Pancreatic Adenocarcinoma | Pancreatic Carcinoma | Metastatic Pancreatic Cancer | Pancreatic Cancer Non-resectable | Metastatic Pancreatic Ductal Adenocarcinoma | Pancreatic Carcinoma... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CelgeneWithdrawnPancreatic Ductal Adenocarcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
University of UtahNovartis PharmaceuticalsRecruitingMetastatic Pancreatic Carcinoma | Unresectable Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedPancreatic Adenocarcinoma | Resectable Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer | Poorly Differentiated Malignant Neoplasm | Undifferentiated Pancreatic CarcinomaUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Celgene CorporationCompletedPancreatic Adenocarcinoma | Resectable Pancreatic CarcinomaUnited States
-
Laser Tissue Welding, Inc.National Cancer Institute (NCI); CHI St. Luke's Health, TexasCompletedPancreatic Neoplasms | Pancreatic Adenocarcinoma | Pancreatic Cyst | Pancreatic Neuroendocrine Tumor | Pancreatic Polypeptide Tumor | Pancreatic Pseudocyst | Pancreatic Glucagonoma | Pancreas Injury | Pancreatic Cystadenoma | Pancreatic Tumor, Benign | Pancreas; Insulinoma | Pancreatic Teratoma | Pancreatic Vipoma and other conditionsUnited States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingLocally Advanced Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer | Pancreatic NeoplasmChina
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer